Corbus Pharmaceuticals
CRBP
$38.77
Share price
1.49%
Change (1 day)
344.61%
Change (1 year)
Categories
Corbus Pharmaceuticals (CRBP) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $35.17 M
According to Corbus Pharmaceuticals 's latest financial reports the company's total liabilities are $35.17 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Corbus Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $35.17 M | 5.57% |
| 2022-12-31 | $33.32 M | -13.72% |
| 2021-12-31 | $38.62 M | -32.27% |
| 2020-12-31 | $57.02 M | 32.65% |
| 2019-12-31 | $42.98 M | 120.83% |
| 2018-12-31 | $19.46 M | 111.7% |
| 2017-12-31 | $9.19 M | 2.52% |
| 2016-12-31 | $8.96 M | 130.55% |
| 2015-12-31 | $3.89 M | 427.11% |
| 2014-12-31 | $0.73 M | -64.67% |
| 2013-12-31 | $2.08 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | $33.62 M | -4.41% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.10 B | 194.31% | 🇺🇸 USA |
 Advaxis ADXS | $40.99 M | 16.54% | 🇺🇸 USA |